SHORT-TERM LOANS	6 Months Ended
Jun. 30, 2025
SHORT-TERM LOANS
SHORT-TERM LOANS	NOTE 7 – SHORT-TERM LOANS On November 4, 2024, the Company entered into a loan agreement with a related party for a principal amount of $120,000. The loan bears interest at an annual rate of 8.5% and is required to be repaid in full no later than December 31, 2025. The loan was repaid on May 21, 2025. On December 15, 2024, the Company entered into a short-term loan agreement with a third-party lender for a principal amount of $180,000. The loan bears interest at an annual rate of 8.5% and is required to be repaid in full no later than December 31, 2025. The loan was repaid on May 21, 2025. On January 30, 2025, the Company entered into a short-term loan agreement with a third-party lender for a principal amount of $750,000. The loan bears interest at an annual rate of 11% and is required to be repaid in full no later than August 31, 2025. The loan was repaid on May 20, 2025. On March 6, 2025, the Company entered into a short-term loan agreement with a third-party lender for a principal amount of approximately $100,000. The outstanding principal accrues interest at an annual rate equal to the Bank of Israel’s official monetary interest rate plus 1.5%, as published on the first business day of each calendar month. The loan is required to be repaid in full no later than March 6, 2026. On March 13, 2025, the Company entered into a short-term loan agreement with a third-party lender for a principal amount of approximately $50,000. The maturity date of the loan was April 14, 2025. The loan was non-interest bearing and was repaid in full on April 6, 2025. Except for transactions and balances related to loans and share-based compensation to officers and directors, the Company did not engage in any other transactions or maintain any balances with related parties or executive officers during the six months period ended June 30, 2025.

SHORT-TERM LOANS

6 Months Ended

Jun. 30, 2025

NOTE 7 – SHORT-TERM LOANS

On November 4, 2024, the Company entered into a loan agreement with a related party for a principal amount of $120,000. The loan bears interest at an annual rate of 8.5% and is required to be repaid in full no later than December 31, 2025. The loan was repaid on May 21, 2025.

On December 15, 2024, the Company entered into a short-term loan agreement with a third-party lender for a principal amount of $180,000. The loan bears interest at an annual rate of 8.5% and is required to be repaid in full no later than December 31, 2025. The loan was repaid on May 21, 2025.

On January 30, 2025, the Company entered into a short-term loan agreement with a third-party lender for a principal amount of $750,000. The loan bears interest at an annual rate of 11% and is required to be repaid in full no later than August 31, 2025. The loan was repaid on May 20, 2025.

On March 6, 2025, the Company entered into a short-term loan agreement with a third-party lender for a principal amount of approximately $100,000. The outstanding principal accrues interest at an annual rate equal to the Bank of Israel’s official monetary interest rate plus 1.5%, as published on the first business day of each calendar month. The loan is required to be repaid in full no later than March 6, 2026.

On March 13, 2025, the Company entered into a short-term loan agreement with a third-party lender for a principal amount of approximately $50,000. The maturity date of the loan was April 14, 2025. The loan was non-interest bearing and was repaid in full on April 6, 2025.

Except for transactions and balances related to loans and share-based compensation to officers and directors, the Company did not engage in any other transactions or maintain any balances with related parties or executive officers during the six months period ended June 30, 2025.

BRAINSTORM CELL THERAPEUTICS INC. 10-Q